Rusan Pharma launches TurmaBoost for pain management

Curcuminoids have been approved by the US Food and Drug Administration (FDA) as “Generally Recognized as Safe” (GRAS), which has good tolerability and safety profiles

Mumbai based Rusan Pharma, a company specializing in the treatment of ’Addiction and Pain Management’ has recently launched their new product “TurmaBoost” with the key ingredient of Turmeric (Haldi) which is recognized for medical properties because of the polyphenol curcumin source.

Curcuminoids have been approved by the US Food and Drug Administration (FDA) as “Generally Recognized as Safe” (GRAS), which has good tolerability and safety profiles.

Commenting on the launch, Malavika Kaura Saxena, Director – Domestic Marketing at Rusan Pharma Limited said: ‘’We are delighted to launch TurmaBoost with the benefits of Turmeric (Haldi) as it is known from centuries for its medicinal & anti-oxidant properties. The consumption of this product can help one to deal with orthopedic, cardio issues, also promotes weight loss, anti-aging and improves the immune system, fight against cancer, and depression.”

Curcumin is the compound found in turmeric which has anti-inflammatory properties. Most high-quality studies and a recent review of the literature on turmeric have significantly shown the effectiveness of curcumin in the combination with anti-depressant medication or other botanicals, for the treatment of a typical and major depression disorder; crucially improvements in anxiety have found with curcumin use as well. 

The mechanism action of curcumin helps in lowering the above symptoms are inhibition of monoamine oxidase A & B enzymes. The modulation of the neurotransmitter levels in the brain. It helps in increasing brain-derived neutrophic factor levels and anti-inflammatory. Curcumin is safe even in the high dose form.